Cardiocast

Reducing heart failure readmissions raises mortality


 

This week from MDedge Cardiology, the Hospital Readmissions Reduction Program may be doing more harm than good, ticagrelor holds no edge over aspirin in CABG patients, weight-loss apps lack evidence, and the Surgeon General sends out an alarm.

Subscribe to Cardiocast wherever you get your podcasts.

Amazon Alexa
Apple Podcasts

Recommended Reading

HF unlikely in pregnant cancer survivors without history of cardiotoxicity
MDedge Cardiology
Antimalarial-induced cardiomyopathy in lupus may be underrecognized
MDedge Cardiology
Heart cell transplant rejections
MDedge Cardiology
Palliative care update highlights role of nonspecialists
MDedge Cardiology
Exercise improves outcomes for patients with heart failure and OSA
MDedge Cardiology
PIONEER-HF secures place for sacubitril/valsartan in this heart failure doc’s practice
MDedge Cardiology
PIONEER-HF called “practice changing” for acute decompensated heart failure
MDedge Cardiology
Mylan issues voluntary recall of certain valsartan-containing products
MDedge Cardiology
Heart disease remains the leading cause of death in U.S.
MDedge Cardiology
TRED-HF: Despite recovery, dilated cardiomyopathy returns after halting HF drugs
MDedge Cardiology